We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Astera Labs beat Q4 estimates with EPS of 58 cents and revenue up 91.8% year over year.
ALAB's growth was driven by new AI platform ramps, though gross margin slipped to 75.7%.
Astera Labs guided Q1 revenues of $286M-$297M and EPS of 53-54 cents per share.
Astera Labs (ALAB - Free Report) reported fourth-quarter 2025 non-GAAP earnings of 58 cents per share, surpassing the Zacks Consensus Estimate by 12.75%. The company reported earnings of 37 cents per share in the year-ago quarter.
Net revenues surged 91.8% year over year to $270.6 million, surpassing the Zacks Consensus Estimate by 8.33%. Growth was driven by new AI platform ramps featuring multiple product families.
ALAB shares plunged 11.85% in pre-market trading.
ALAB’s Operating Details
The non-GAAP gross margin was 75.7%, contracting 160 basis points year over year.
Astera Labs, Inc. Price, Consensus and EPS Surprise
Research and development expenses surged 65.9% year over year to $93.8 million.
Sales and marketing expenses decreased 11.9% year over year to $20.1 million. General and administrative expenses increased 6.8% year over year to $23.6 million.
The non-GAAP operating margin was 40.2% compared with 34.3% in the year-ago quarter.
ALAB’s Balance Sheet Details
As of Dec. 31, 2025, cash and cash equivalents and marketable securities were $1.18 billion compared with $1.13 billion as of Sept. 30, 2025.
ALAB’s Q1 Guidance
Astera Labs expects first-quarter 2026 revenues between $286 million and $297 million.
Non-GAAP gross margin is expected to be roughly 74%. Non-GAAP operating expenses are expected to be between $112 million and $118 million.
Earnings are expected to be between 53 cents and 54 cents per share for the first quarter.
ALAB’s Zacks Rank & Stocks to Consider
Astera Labs currently carries a Zacks Rank #3 (Hold).
Analog Devices’ shares have gained 60.3% in the past 12-month period. Analog Devices is scheduled to release first-quarter 2026 results on Feb. 18, 2026.
Applied Materials shares have returned 79.8% in the past 12-month period. AMAT is scheduled to release its first-quarter 2026 results on Feb. 12, 2026.
MKS shares have gained 127.7% in the past 12-month period. MKS is set to report its fourth-quarter 2025 results on Feb. 17, 2026.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Astera Labs Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall
Key Takeaways
Astera Labs (ALAB - Free Report) reported fourth-quarter 2025 non-GAAP earnings of 58 cents per share, surpassing the Zacks Consensus Estimate by 12.75%. The company reported earnings of 37 cents per share in the year-ago quarter.
Net revenues surged 91.8% year over year to $270.6 million, surpassing the Zacks Consensus Estimate by 8.33%. Growth was driven by new AI platform ramps featuring multiple product families.
ALAB shares plunged 11.85% in pre-market trading.
ALAB’s Operating Details
The non-GAAP gross margin was 75.7%, contracting 160 basis points year over year.
Astera Labs, Inc. Price, Consensus and EPS Surprise
Astera Labs, Inc. price-consensus-eps-surprise-chart | Astera Labs, Inc. Quote
Research and development expenses surged 65.9% year over year to $93.8 million.
Sales and marketing expenses decreased 11.9% year over year to $20.1 million. General and administrative expenses increased 6.8% year over year to $23.6 million.
The non-GAAP operating margin was 40.2% compared with 34.3% in the year-ago quarter.
ALAB’s Balance Sheet Details
As of Dec. 31, 2025, cash and cash equivalents and marketable securities were $1.18 billion compared with $1.13 billion as of Sept. 30, 2025.
ALAB’s Q1 Guidance
Astera Labs expects first-quarter 2026 revenues between $286 million and $297 million.
Non-GAAP gross margin is expected to be roughly 74%. Non-GAAP operating expenses are expected to be between $112 million and $118 million.
Earnings are expected to be between 53 cents and 54 cents per share for the first quarter.
ALAB’s Zacks Rank & Stocks to Consider
Astera Labs currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks Computer and Technology sector include Analog Devices (ADI - Free Report) , Applied Materials (AMAT - Free Report) , and MKS (MKSI - Free Report) . While MKSI sports a Zacks Rank #1 (Strong Buy), Analog Devices and Applied Materials carry a Zacks Rank of 2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Analog Devices’ shares have gained 60.3% in the past 12-month period. Analog Devices is scheduled to release first-quarter 2026 results on Feb. 18, 2026.
Applied Materials shares have returned 79.8% in the past 12-month period. AMAT is scheduled to release its first-quarter 2026 results on Feb. 12, 2026.
MKS shares have gained 127.7% in the past 12-month period. MKS is set to report its fourth-quarter 2025 results on Feb. 17, 2026.